On May 9, 2024, Eledon Pharmaceuticals, Inc closed the transaction. The company has received $49,999,010 from 24 investors pursuant to exemption provided under Regulation D. The company has paid fees $1,617,174 to placements.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | +4.94% | -9.24% | +52.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.78% | 10Cr | |
+15.26% | 12TCr | |
+20.04% | 11TCr | |
+8.24% | 2.28TCr | |
-20.44% | 2.07TCr | |
-16.19% | 1.65TCr | |
-13.30% | 1.64TCr | |
-44.35% | 1.58TCr | |
+1.49% | 1.35TCr | |
+67.91% | 1.17TCr |
- Stock Market
- Equities
- ELDN Stock
- News Eledon Pharmaceuticals, Inc.
- Eledon Pharmaceuticals, Inc. announced that it has received $49.99901 million in funding